Division of Infectious Diseases

Building sustainable biomedical informatics training and research capacity to address gaps in Mozambique's national HIV response will help the country leverage newer data-driven and genetics-based approaches for personalized HIV care and molecular epidemiology of the disease.

Vanderbilt's Scott Smith, MD, PhD, has been awarded a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to study the human immune response to tick bites and its role in preventing tick-borne illnesses.

Infectious diseases researcher H. Keipp Talbot, MD, MPH, has been appointed chair of the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention.

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.

The Tennessee Emerging Infections Program has been awarded a new five-year grant from the Centers for Disease Control and Prevention to continue infectious disease surveillance research that has been conducted since 1999, and has expanded to include COVID, Mpox and HPV surveillance into oropharyngeal cancers.

A new study led by Vanderbilt University Medical Center researchers has identified key immune cell populations that predict how well pediatric hematopoietic stem cell transplant (HCT) recipients will respond to the influenza vaccine.

The Vanderbilt Comprehensive Care Clinic, Nashville’s original nonprofit medical home for people living with HIV, will hold its annual Ruby Gala on Saturday, Feb. 10, 2024, at Marathon Music Works.